Naïm Bouazza

2.6k total citations
94 papers, 1.6k citations indexed

About

Naïm Bouazza is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Naïm Bouazza has authored 94 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 29 papers in Pediatrics, Perinatology and Child Health and 19 papers in Epidemiology. Recurrent topics in Naïm Bouazza's work include HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (17 papers). Naïm Bouazza is often cited by papers focused on HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (17 papers). Naïm Bouazza collaborates with scholars based in France, United States and Burkina Faso. Naïm Bouazza's co-authors include Jean‐Marc Tréluyer, Saı̈k Urien, Frantz Foissac, Déborah Hirt, Sihem Benaboud, Nicolas Barry Delongchamps, F. Cornud, Frédéric Beuvon, T Flam and Marc Zerbib and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Naïm Bouazza

87 papers receiving 1.6k citations

Peers

Naïm Bouazza
Naïm Bouazza
Citations per year, relative to Naïm Bouazza Naïm Bouazza (= 1×) peers Olivier Moranne

Countries citing papers authored by Naïm Bouazza

Since Specialization
Citations

This map shows the geographic impact of Naïm Bouazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naïm Bouazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naïm Bouazza more than expected).

Fields of papers citing papers by Naïm Bouazza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naïm Bouazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naïm Bouazza. The network helps show where Naïm Bouazza may publish in the future.

Co-authorship network of co-authors of Naïm Bouazza

This figure shows the co-authorship network connecting the top 25 collaborators of Naïm Bouazza. A scholar is included among the top collaborators of Naïm Bouazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naïm Bouazza. Naïm Bouazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouazza, Naïm, Frantz Foissac, Saı̈k Urien, et al.. (2025). Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study. Placenta. 168. 150–158.
2.
Foissac, Frantz, Naïm Bouazza, Inès Gana, et al.. (2024). Optimization of vigabatrin dosage in children with epileptic spasms: A population pharmacokinetic approach. British Journal of Clinical Pharmacology. 90(8). 1900–1910. 1 indexed citations
3.
Thy, Michaël, Saı̈k Urien, Naïm Bouazza, et al.. (2024). Impact of pediatric continuous renal replacement therapy parameters on meropenem, piperacillin, and tazobactam pharmacokinetics: an in vitro model. Expert Opinion on Drug Metabolism & Toxicology. 21(3). 325–333.
4.
Bouazza, Naïm, et al.. (2023). Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database. BMC Pediatrics. 23(1). 321–321. 5 indexed citations
5.
Bouazza, Naïm, Gilles Cambonie, Cyril Flamant, et al.. (2023). Prophylactic Intravenous Acetaminophen in Extremely Premature Infants: Minimum Effective Dose Research by Bayesian Approach. Pediatric Drugs. 26(1). 83–93.
6.
Bouazza, Naïm, Aristides Dokoumetzidis, Catherijne A. J. Knibbe, et al.. (2022). General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children. British Journal of Clinical Pharmacology. 88(12). 4985–4996. 2 indexed citations
7.
Thy, Michaël, Saı̈k Urien, Frantz Foissac, et al.. (2022). Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy. Antimicrobial Agents and Chemotherapy. 66(12). e0113522–e0113522. 5 indexed citations
8.
Thy, Michaël, Saı̈k Urien, Naïm Bouazza, et al.. (2022). Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy. Clinical Pharmacokinetics. 61(11). 1609–1621. 6 indexed citations
9.
Diana, Jean‐Sébastien, Naïm Bouazza, Martin Castelle, et al.. (2022). Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency. Frontiers in Pediatrics. 9. 804912–804912. 1 indexed citations
10.
Zheng, Yi, Gabrielle Lui, Naïm Bouazza, et al.. (2021). Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 196. 113923–113923. 6 indexed citations
11.
Lê, Minh, Naïm Bouazza, Florence Gattacceca, et al.. (2020). Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients. British Journal of Clinical Pharmacology. 86(12). 2404–2413. 9 indexed citations
12.
Hoss, Sara El, Sylvie Cochet, Mickaël Marin, et al.. (2019). Insights into determinants of spleen injury in sickle cell anemia. Blood Advances. 3(15). 2328–2336. 26 indexed citations
13.
Urien, Saı̈k, Frantz Foissac, Naïm Bouazza, et al.. (2019). Population pharmacokinetics of meropenem in critically ill children with different renal functions. European Journal of Clinical Pharmacology. 76(1). 61–71. 33 indexed citations
14.
Bouazza, Naïm, Isabelle Aerts, Birgit Geoerger, et al.. (2018). Parents’ and children’s comprehension and decision in a paediatric early phase oncology trial: a prospective study. Archives of Disease in Childhood. 104(10). 947–952. 8 indexed citations
15.
Bouazza, Naïm, Annick Robinson, Nadjet Benhaddou, et al.. (2017). Prevalence of Mycoplasma pneumoniae Infection in Malagasy Children. The Pediatric Infectious Disease Journal. 36(5). 467–471. 8 indexed citations
16.
Bouazza, Naïm, Tim R. Cressey, Frantz Foissac, et al.. (2016). Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients. Journal of Antimicrobial Chemotherapy. 72(2). 490–495. 3 indexed citations
17.
Bouazza, Naïm, Zoubir Djerada, Claire Gozalo, et al.. (2016). Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. European Journal of Clinical Pharmacology. 72(11). 1373–1379. 3 indexed citations
18.
Cressey, Tim R., Naïm Bouazza, Linda Aurpibul, et al.. (2015). Efavirenz Concentrations and Probability of HIV Replication in Children. The Pediatric Infectious Disease Journal. 34(11). 1214–1217. 6 indexed citations
19.
Bouazza, Naïm, Saı̈k Urien, Stéphane Blanche, et al.. (2014). Concentration-response Model of Lopinavir/Ritonavir in HIV-1–infected Pediatric Patients. The Pediatric Infectious Disease Journal. 33(8). e213–e218. 9 indexed citations
20.
Benaboud, Sihem, Jean‐Marc Tréluyer, Saı̈k Urien, et al.. (2011). Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women. Antimicrobial Agents and Chemotherapy. 56(2). 776–782. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026